Jaylee Biotech Private Limited
Manufacturer of pesticides, agro chemicals, bio-technology, and fertilizers with research and consultancy services.
2012 | Aurangabad, Maharashtra (India) | Active
Jaylee Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 14 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.00 M
- Revenue Growth 0.27%
- Profit Growth -71.11%
- Ebitda -15.49%
- Net Worth 6.50%
- Total Assets -5.22%
About Jaylee Biotech
Jaylee Biotech Private Limited (JBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 2012 and has a history of 13 years. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Seema Sawant and Pratik Sawant serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01403MH2012PTC226892
- Company No.
226892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2012
- Date of AGM
27 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Agriculture
Who are the key members and board of directors at Jaylee Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Sawant  | Director | 14-Feb-2012 | Current |
| Pratik Sawant | Director | 14-Feb-2012 | Current |
Financial Performance of Jaylee Biotech.
Jaylee Biotech Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 0.27% increase. The company also saw a substantial fall in profitability, with a 71.11% decrease in profit. The company's net worth moved up by a moderate rise of 6.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaylee Biotech?
In 2017, Jaylee Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹2.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2015 | Idbi Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Jaylee Biotech?
Unlock and access historical data on people associated with Jaylee Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaylee Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaylee Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
